Overexpression of miR-181a levels were found in insulin-resistant cultured hepatocytes, and inhibition of miR-181a may lead to increased protein levels of SIRT1, which is a potential therapeutic target for combating insulin resistance, and thereby improving hepatic insulin sensitivity [33]. Here, INS is linked to Insulin resistance.